News & Updates

New Publication on Drug Development and Patient Access is Now Available

November 21, 2019

New Publication on Drug Development and Patient Access is Now Available


Washington, DC- Earlier this year, the National Academies of Sciences, Engineering, and Medicine, formerly the Institute of Medicine, announced the selection of national experts to serve on an ad hoc committee on drug development and patient access. IMI’s own founding executive director, Dr. Jennifer Moore, was among the distinguished group. The committee was then tasked with exploring the following topics:

  • how federal funding for biomedical research, particularly via the National Institutes of Health (NIH), has contributed to new drug development, both directly and indirectly;
  • the pricing of drugs that have benefited from federal investments in biomedical science;
  • the role of technology and patent transfer to and from entrepreneurial organizations associated with NIH-funded research;
  • potential ways to better track, quantify, and document NIH contributions to innovation in drug development; and
  • potential strategies and polices to facilitate the translation of federally-funded biomedical research into innovations in drug development and to help ensure that the public has affordable access to those innovative medicines.

On July 24-25, 2019, the committee, along with invited subject matter experts, met and presented information in a public workshop entitled, “The Role of NIH in Drug Development Innovation and its Impact on Patient Access.” Based on their presentation, NASEM and a handful of other contributing partners have produced a publication summarizing several the major findings and discussions from the two-day meeting.

The publication is now available and is accessible here for free download.


About the Institute for Medicaid Innovation

The Institute for Medicaid Innovation (IMI) is a 501(c)3 nonprofit, nonpartisan research and policy organization that provides independent, nonpartisan information and analysis to inform Medicaid policy and improve the health of the nation.


Media contact:

Lydia Tonkonow